The global DNA & RNA Banking Services market size is expected to be worth around US$ 9.01 billion by 2030, according to a new report by Vision Research Reports.
The global DNA & RNA Banking Services market size was valued at US$ 7.01 billion in 2020 and is anticipated to grow at a CAGR of 5.50% during forecast period 2021 to 2030.
Biospecimens such as DNA and RNA are critical for biomarker discovery, thereby providing a path for the expansion of personalized medicine. Moreover, progress in translational and clinical research through an introduction of advanced, standardized cell isolation methodologies reduces hands-on-time. The development of automated solutions and the transformation of biobanks into fully automated biobanks potentially accelerate the growth of the market.
A rise in the enrollment of individuals for personalized medicine initiatives drives the revenue generation for DNA and RNA banking services. In July 2019, Partners HealthCare, U.S. enrolled more than 100,000 individuals in its precision medicine biobank that supported clinicians and researchers of the Brigham and Women’s Hospital, U.S., and other partners. Such initiative assisted in examining the impact of several factors on disease and health.
Storage service dominated the market with a revenue share of 35.9% in 2020. The acquisition of high-quality biospecimens is vital for researchers. Reliable long-term stabilization and storage of DNA and RNA are critical for the success of biobanks. It is essential to store biological samples in fully qualified, temperature-controlled storage, such as -196°C; -80°C; -20°C; 2.0°C-8.0°C; and 15.0°C-25.0°C.
The availability of systems, such as comPOUND and arktic systems from SPT Labtech, can be configured for ambient, -20°C and 4°C storage and -80°C solutions, respectively. These platforms are well-suited for a broad range of 2D barcoded sample tubes to fulfill storage volumes ranging from a few microliters to 1.2 mL. Therefore, the presence of solutions for ambient DNA and RNA storage positively impacts the segment growth.
Quality control services are anticipated to register the fastest growth rate during the forecast period with the presence of several guidelines to improve the quality and reproducibility of DNA and RNA samples. The Biospecimen Reporting for Improved Study Quality guidelines strengthen the communication and publications related to biospecimen research. On the other hand, France introduced stringent country-specific regulations for banking procedures.
The blood segment accounted for the largest share of 39.8% in 2020as it is the most recommended sample type for routine care applications. It is proven to be the most popular specimen type for non-invasive biomarker-based cancer studies. In addition, the time of collecting blood samples does not impact the yield of DNA and RNA.
Though the collection of blood requires certified skills, venipuncture, and special collection tubes, it is a part of routine clinical care. The collection of an additional specimen for storage in biobanks does not burden the patient, thus making blood collection relatively uncomplicated. In addition, serum and plasma are usually preferred over whole blood for cell-free DNA, hormone, and protein as the removed cellular fraction cannot interfere with the results.
Buccal swabs and hair follicle samples are anticipated to expand at a lucrative CAGR over the forecast period. The collection of biological samples from buccal swabs is among the fastest methods and it does not require medically trained personnel. Hair samples are commonly used in forensic studies and usually are not suggested for genetic studies. Moreover, a rise in COVID-19 cases has exponentially increased the demand for swabbing methods for diagnostic testing.
In terms of revenue, drug discovery and clinical research accounted for the largest revenue share of 37.2% in 2020 as DNA and RNA banking services support the scientific progress in the stratification of population and biomarker discovery. These services are important for new drug discovery and clinical research processes. It helps support the entire procedure of patient prevention and prediction, therapy monitoring, follow-up, and therapy optimization.
The paradigm shift toward has further driven the market for drug discovery and clinical research. Personalized medicine is based on , metabolomics, and epigenomics, which involves the usage of DNA and RNA samples for research purposes into new treatments for disease. These biobanks provide data related to the genotype-phenotype correlations and offer follow-up data to link genetic variation with health outcomes.
DNA and RNA biobanks conduct a wide range of studies for infectious diseases and immunization, which enrolls several hundreds of participants every year. This creates significant opportunities to store DNA and RNA samples for future research on immunity, infectious diseases, and immunization. For instance, the Oxford Vaccine Centre collects DNA and RNA samples to offer data related to immunization and infectious diseases, resulting in the lucrative growth of the therapeutics segment.
The academic research segment dominated the DNA and RNA banking services market with a revenue share of 32.8% in 2020. The value of DNA and RNA biobanks is well recognized by translational researchers at academic institutions and laboratories. The shifting paradigm toward personalized medicine, tailored therapies, and benefits offered by can be attributed to the largest revenue share of the segment. Academic and research centers are involved in understanding the differences between medical treatments and responses of different individuals.
One such academic institute is the Colorado Center for Personalized Medicine (CCPM) which is engaged in the field of personalized medicine. This center is also a biobank that collects, processes, stores, and tests biological samples. The clinical genetic tests help in the prediction of medications, a carrier for a disease, and the risk of certain diseases.
The hospitals and diagnostic centers segment is expected to witness the fastest growth from 2021 to 2027 with an increase in the number of patients that have consented to provide specimens for hospitals. For instance, over 80,000 patients have consented to provide their biological samples to the Partners Biobank at McLean Hospital, Massachusetts General Hospital, Brigham and Women’s Hospital, and Spaulding Rehabilitation Hospital to date.
North America dominated the market with a share of 33.4% in 2020. This can be attributed to the presence of several biobanks and continuous efforts undertaken in this region. The Canadian Tumor Repository Network is a non-profit biobanks consortium that is funded by the Government of Canada. The biobank participating in this consortium collects and stores blood, tissue, and saliva samples of cancer patients for several research applications.
DNA Genotek Inc.
US Biolab Corporation, Inc.
Thermo Fisher Scientific, Inc.
Brooks Life Sciences
LGC Biosearch Technologies
Service Type Outlook
Quality Control Service
Specimen Type Outlook
Buccal Swabs & Hair Follicles
Drug Discovery & Clinical Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Middle East Africa (MEA)
The DNA & RNA Banking Services market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of DNA & RNA Banking Services market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global DNA & RNA Banking Services market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the DNA & RNA Banking Services market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted DNA & RNA Banking Services market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the DNA & RNA Banking Services capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of DNA & RNA Banking Services by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global DNA & RNA Banking Services market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major DNA & RNA Banking Services market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of DNA & RNA Banking Services market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the DNA & RNA Banking Services industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The DNA & RNA Banking Services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to DNA & RNA Banking Services market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of DNA & RNA Banking Services market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new DNA & RNA Banking Services market. These factors have benefited the growth of the global market for DNA & RNA Banking Services. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for DNA & RNA Banking Services. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of DNA & RNA Banking Services are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Retinal Disorders Treatment Market (By Indication: Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, and Others; By Therapeutic Class; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Dystrophic Epidermolysis Bullosa Treatment Market (By Treatment Type: Antibiotics, Corticosteroids, Opioid Analgesics, Anticonvulsant, Others; By Disease Type: DDEB and RDEB; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Bromelain Market (By Application: Food & Beverages, Healthcare & Pharmaceuticals, Cosmetics, and Other Industries; By Source: Stem and Fruit) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Chronic Idiopathic Constipation Treatment Market (By Drug Class: Serotonin-4 [5-Ht4] Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, Others; By Route of Administration: Oral and Rectal; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Hemoglobin Feed Market (By Source: Bovine, Swine, Poultry, Shark, Synthetic, Others; By Application: Industrial and Commercial) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...